Man Group PLC G1 Therapeutics, Inc. Transaction History

Man Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.2 - $4.98 $324,797 - $735,222	-147,635 Reduced 53.62%	127,723 $291,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $270,253 - $621,582	128,692 Added 87.74%	275,358 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $164,265 - $547,064	146,666 New	146,666 $447,000
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $66,239 - $210,315	25,774 Added 108.48%	49,534 $132,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $123,314 - $320,760	23,760 New	23,760 $129,000
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $228,969 - $307,944	-11,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $1.5 Million - $2.77 Million	-85,049 Reduced 87.91%	11,700 $282,000
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $364,868 - $677,280	33,200 Added 52.24%	96,749 $1.74 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $733,990 - $1.51 Million	63,549 New	63,549 $734,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.